ArticleFrontiers in immunology2022

Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer.

Junquan Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.